Dennis D Kim - Net Worth and Insider Trading
Dennis D Kim Net Worth
The estimated net worth of Dennis D Kim is at least $651,369 dollars as of 2024-11-13. Dennis D Kim is the Chief Medical Officer of CymaBay Therapeutics Inc and owns about 20,000 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $649,600. Dennis D Kim is also the Chief Medical Officer of Zafgen Inc and owns about 1,787 shares of Zafgen Inc (ZFGN) stock worth over $1,769. Details can be seen in Dennis D Kim's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dennis D Kim has not made any transactions after 2023-04-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dennis D Kim
Dennis D Kim Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis D Kim owns 4 companies in total, including Skye Bioscience Inc (SKYE) , Larimar Therapeutics Inc (LRMR) , and Orexigen Therapeutics Inc (OREXQ) among others .
Click here to see the complete history of Dennis D Kim’s form 4 insider trades.
Insider Ownership Summary of Dennis D Kim
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SKYE | Skye Bioscience Inc | 2019-08-21 | Chief Medical Officer |
| LRMR | Larimar Therapeutics Inc | 2015-09-14 | Chief Medical Officer |
| OREXQ | Orexigen Therapeutics Inc | 2009-04-23 | Sr. VP & Corporate Development |
 | | 2023-04-17 | Chief Medical Officer |
Dennis D Kim Latest Holdings Summary
Dennis D Kim currently owns a total of 2 stocks. Among these stocks, Dennis D Kim owns 20,000 shares of CymaBay Therapeutics Inc (CBAY) as of April 17, 2023, with a value of $649,600 and a weighting of 99.73%. Dennis D Kim also owns 1,787 shares of Zafgen Inc (ZFGN) as of July 11, 2017, with a value of $1,769 and a weighting of 0.27%.
Latest Holdings of Dennis D Kim
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2023-04-17 | 20,000 | 32.48 | 649,600 |
| ZFGN | Zafgen Inc | 2017-07-11 | 1,787 | 0.99 | 1,769 |
Holding Weightings of Dennis D Kim
Dennis D Kim Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennis D Kim has made a total of 3 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in CymaBay Therapeutics Inc is the sale of 120,000 shares on April 17, 2023, which brought Dennis D Kim around $1 Million.
According to the SEC Form 4 filings, Dennis D Kim has made a total of 0 transactions in Zafgen Inc (ZFGN) over the past 5 years. The most-recent trade in Zafgen Inc is the acquisition of 833 shares on July 11, 2017, which cost Dennis D Kim around $33,900.
Insider Trading History of Dennis D Kim
- 1
Dennis D Kim Trading Performance
GuruFocus tracks the stock performance after each of Dennis D Kim's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dennis D Kim is -3.94%. GuruFocus also compares Dennis D Kim's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dennis D Kim within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dennis D Kim's insider trading performs compared to the benchmark.
Performance of Dennis D Kim
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.54 | | | | | |
| Relative Return to S&P 500(%) | 2.16 | | | | | |
Dennis D Kim Ownership Network
Ownership Network List of Dennis D Kim
Ownership Network Relation of Dennis D Kim
Dennis D Kim Owned Company Details
What does Skye Bioscience Inc do?
Who are the key executives at Skye Bioscience Inc?
Dennis D Kim is the Chief Medical Officer of Skye Bioscience Inc. Other key executives at Skye Bioscience Inc include 10 percent owner 5am Partners Vii, Llc , director & 10 percent owner Andrew J. Schwab , and 10 percent owner John D Diekman .
Skye Bioscience Inc (SKYE) Insider Trades Summary
Over the past 18 months, Dennis D Kim made no insider transaction in Skye Bioscience Inc (SKYE). Other recent insider transactions involving Skye Bioscience Inc (SKYE) include a net purchase of 5,389,737 shares made by 5am Partners Vii, Llc , a net purchase of 1,762,000 shares made by Punit Dhillon , and a net sale of 266,337 shares made by Andrew J. Schwab .
In summary, during the past 3 months, insiders sold 532,674 shares of Skye Bioscience Inc (SKYE) in total and bought 0 shares, with a net sale of 532,674 shares. During the past 18 months, 532,674 shares of Skye Bioscience Inc (SKYE) were sold and 5,663,122 shares were bought by its insiders, resulting in a net purchase of 5,130,448 shares.
Skye Bioscience Inc (SKYE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Skye Bioscience Inc Insider Transactions
Dennis D Kim Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis D Kim. You might contact Dennis D Kim via mailing address: C/o Emerald Bioscience, Inc., 130 North Marina Drive, Long Beach Ca 90803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
